Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. uri icon

authors

  • Joseph-Mathurin, Nelly
  • Wang, Qing
  • Gordon, Brian A
  • Chen, Charles D
  • Flores, Shaney
  • Aggarwal, Neelum T
  • Berman, Sarah B
  • Bird, Thomas D
  • Black, Sandra E
  • Borowski, Bret
  • Brooks, William S
  • Llibre-Guerra, Jorge J
  • Chhatwal, Jasmeer P
  • Clarnette, Roger
  • Cruchaga, Carlos
  • Fagan, Anne M
  • Farlow, Martin
  • Fox, Nick C
  • Gauthier, Serge
  • Hassenstab, Jason
  • Hobbs, Diana A
  • Holdridge, Karen C
  • Li, Yan
  • Honig, Lawrence S
  • Hornbeck, Russ C
  • Hsiung, Ging-Yuek R
  • Jack, Clifford R
  • Jimenez-Velazquez, Ivonne Z
  • Jucker, Mathias
  • Klein, Gregory
  • Levin, Johannes
  • Mancini, Michele
  • Masellis, Mario
  • McCullough, Austin A
  • McKay, Nicole S
  • Mummery, Catherine J
  • Ringman, John M
  • Shimada, Hiroyuki
  • Snider, B Joy
  • Suzuki, Kazushi
  • Wallon, David
  • Xiong, Chengjie
  • Yaari, Roy
  • McDade, Eric
  • Hofmann, Carsten
  • Perrin, Richard J
  • Bateman, Randall J
  • Salloway, Stephen P
  • Benzinger, Tammie L S
  • Clifford, David B
  • Wojtowicz, Jakub
  • Park, Ethan
  • Wang, Guoqiao
  • Preboske, Gregory M

publication date

  • January 1, 2022